Wendt Michael D, Rockway Todd W, Geyer Andrew, McClellan William, Weitzberg Moshe, Zhao Xumiao, Mantei Robert, Nienaber Vicki L, Stewart Kent, Klinghofer Vered, Giranda Vincent L
Cancer Research and Structural Biology, Global Pharmaceutical R & D, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6101, USA.
J Med Chem. 2004 Jan 15;47(2):303-24. doi: 10.1021/jm0300072.
The preparation and assessment of biological activity of 6-substituted 2-naphthamidine inhibitors of the serine protease urokinase plasminogen activator (uPA, or urokinase) is described. 2-Naphthamidine was chosen as a starting point based on synthetic considerations and on modeling of substituent vectors. Phenyl amides at the 6-position were found to improve binding; replacement of the amide with other two-atom linkers proved ineffective. The phenyl group itself is situated near the S1' subsite; substitutions off of the phenyl group accessed S1' and other distant binding regions. Three new points of interaction were defined and explored through ring substitution. A solvent-exposed salt bridge with the Asp60A carboxylate was formed using a 4-alkylamino group, improving affinity to K(i) = 40 nM. Inhibitors also accessed two hydrophobic regions. One interaction is characterized by a tight hydrophobic fit made with a small dimple largely defined by His57 and His99; a weaker, less specific interaction involves alkyl groups reaching into the broad prime-side protein binding region near Val41 and the Cys42-Cys58 disulfide, displacing water molecules and leading to small gains in activity. Many inhibitors accessed two of these three regions. Affinities range as low as K(i) = 6 nM, and many compounds had K(i) < 100 nM, while moderate to excellent selectivity was gained versus four of five members of a panel of relevant serine proteases. Also, some selectivity against trypsin was generated via the interaction with Asp60A. X-ray structures of many of these compounds were used to inform our inhibitor design and to increase our understanding of key interactions. In combination with our exploration of 8-substitution patterns, we have identified a number of novel binding interactions for uPA inhibitors.
本文描述了6-取代的2-萘甲脒类丝氨酸蛋白酶尿激酶型纤溶酶原激活剂(uPA,或尿激酶)抑制剂的制备及其生物活性评估。基于合成方面的考虑以及取代基向量的建模,选择2-萘甲脒作为起始点。发现6位的苯甲酰胺可改善结合;用其他双原子连接体取代酰胺证明无效。苯基本身位于S1'亚位点附近;苯基上的取代基可进入S1'和其他较远的结合区域。通过环取代定义并探索了三个新的相互作用点。使用4-烷基氨基形成了与Asp60A羧酸盐的溶剂暴露盐桥,将亲和力提高至K(i)=40 nM。抑制剂还可进入两个疏水区域。一种相互作用的特征是与一个主要由His57和His99定义的小凹陷形成紧密的疏水契合;一种较弱、特异性较低的相互作用涉及烷基伸入Val41和Cys42-Cys58二硫键附近的宽的prime侧蛋白质结合区域,取代水分子并导致活性略有提高。许多抑制剂可进入这三个区域中的两个。亲和力低至K(i)=6 nM,许多化合物的K(i)<100 nM,同时对一组相关丝氨酸蛋白酶的五个成员中的四个具有中度至优异的选择性。此外,通过与Asp60A的相互作用产生了对胰蛋白酶的一些选择性。许多这些化合物的X射线结构用于指导我们的抑制剂设计并增进我们对关键相互作用的理解。结合我们对8-取代模式的探索,我们已经确定了许多uPA抑制剂的新型结合相互作用。